- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Emerging vaccine strategies against the incessant pneumococcal disease ; volume:8 ; number:1 ; day:17 ; month:8 ; year:2023 ; pages:1-9 ; date:12.2023
npj vaccines ; 8, Heft 1 (17.8.2023), 1-9, 12.2023
- Creator
-
Duke, Jeremy A.
Avci, Fikri Y.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00715-w
- URN
-
urn:nbn:de:101:1-2024020515414826395618
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duke, Jeremy A.
- Avci, Fikri Y.
- SpringerLink (Online service)
Other Objects (12)
Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany : A retrospective cohort study
Characterization of pneumococcal serotype 7F in vaccine conjugation
Pneumococcal conjugate vaccine implementation in middle-income countries
Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics
Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany : A retrospective cohort study
Characterization of pneumococcal serotype 7F in vaccine conjugation
Pneumococcal conjugate vaccine implementation in middle-income countries
Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics
Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany : A retrospective cohort study
Characterization of pneumococcal serotype 7F in vaccine conjugation
Pneumococcal conjugate vaccine implementation in middle-income countries
Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics
Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia